Synmosa Biopharma financials at a glance

+ Portfolio

The revenue of Synmosa Biopharma is reported as 4.08252 billion New Dollars in the fiscal year 2023. The earnings were 1.61 New Dollars per share in 2023, which was 28.13 lower than 2022. And about 0.94796 billion New Dollars are reported as free cash flow in the financials of Synmosa Biopharma 2023. Dividends of 0 New Dollars per share were paid to shareholders of Synmosa Biopharma stock TPEX:4114 in fiscal 2023.

NT$4.08B

Revenue

NT$1.61

Earnings Per Share

41.24%

Gross Margin %

NT$0.00M

Free Cash Flow

Revenue

4,082.52

Earnings Per Share

1.61

Gross Margin %

41.24

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2020	2018	2015	2014	2013	2011	2008
Rev.	Revenue	N/A	NT$4.08B	NT$4.39B	NT$3.04B	NT$0.00M	NT$0.00M	NT$1.48B	NT$1.25B	NT$0.00M	NT$756.00M
GM %	Gross Margin %	41.64%	41.24%	41.64%	37.29%	40.13%	46.13%	46.76%	48.75%	47.93%	45.23%
OM	Operating Margin	12.12%	12.00%	10.50%	4.92%	-2.59%	0.94%	-3.49%	3.26%	-3.37%	-1.82%
EPS	Earnings Per Share	NT$1.61	NT$1.61	NT$2.24	NT$1.82	NT$1.22	NT$0.11	NT$0.39	NT$0.24	NT$-0.09	NT$0.05
Div.	Dividends	N/A	NT$0.00	NT$0.55	NT$0.00	NT$0.00	NT$0.00	NT$0.00	NT$0.00	NT$0.00	NT$0.00
PR %	Payout Ratio %	0	0	24.55%	0	0	0	0	0	0	0
Sha.	Shares	N/AM	382.04M	354.72M	360.53M	316.12M	281M	285.01M	268.05M	234.32M	194.29M
OCF	Operating Cash Flow	N/A	NT$1.16B	NT$0.00M	NT$254.40M	NT$0.00M	NT$0.00M	NT$-11.22M	NT$30.25M	NT$0.00M	NT$0.00M
FCF	Free Cash Flow	N/A	NT$947.96M	NT$0.00M	NT$100.00M	NT$0.00M	NT$0.00M	NT$-1,131.27M	NT$-,296.66M	NT$0.00M	NT$0.00M
FCFS	Free Cash Flow Per Share	NT$0.56	NT$0.68	NT$1.25	NT$0.27	NT$-1.46	NT$-1.87	NT$-5.55	NT$-1.66	NT$-0.69	NT$-0.46

Synmosa Biopharma financials at a glance

Financials

Discover